Diagnostic company Amplified Sciences has presented its first human clinical validation data for its second product at the ADLM conference in Chicago in late July. The 70-patient study represents a significant milestone demonstrating the company's platform can deliver multiple diagnostic tools beyond its commercially available pancreatic cancer test. "A company like ours, in terms of […]

Only subscribers get to read this.

Hit SUBSCRIBE for freemium or paid content access.